Cardiotoxicity in African-American patients treated with arsenic trioxide for acute promyelocytic leukemia.
Patel
Sandip P
SP
Garcia-Manero
Guillermo
G
Ferrajoli
Alexandra
A
Faderl
Stefan
S
Verstovek
Serge
S
Kantarjian
Hagop
H
Estey
Elihu
E
D000328:Adult; D001741:Black or African American; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000209:etiology / Q000517:prevention & control; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide